🇺🇸 FDA

Intelligence Platform

Patents

Browse 308 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11034750

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

AUTOLUS LIMITED · Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11021545

Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer

The Regents of the University of California · Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10988537

Antibodies comprising chimeric constant domains

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10981970

Chimeric antigen receptor (CAR) comprising a CD22-binding domain

AUTOLUS LIMITED · Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10975365

Di-enzymatic chimeric endolysin

Government of the United States of America, as represented by the Secretary of Commerce · Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10975162

Chimeric antigen receptor

AUTOLUS LIMITED · Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10968442

Chimeric clotting factors

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10934363

Chimeric antigen receptors based on single domain antibodies and methods of use thereof

LEGEND BIOTECH USA INC. · Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10934337

Anti-BCMA chimeric antigen receptors

Cartesian Therapeutics, Inc. · Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10919951

Chimeric antigen receptor

AUTOLUS LIMITED · Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10900042

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10888581

Chimeric antigen receptor and methods of use thereof

The Regents of the University of California · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10881742

Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10876123

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869911

Chimeric protein

AUTOLUS LIMITED · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10844387

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10837019

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10837003

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of den

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829769

Chimeric antigen receptors targeting b-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829767

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829768

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815488

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815301

Anti-CD30 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815487

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted